The Agency for Healthcare Research and Quality seeks OMB approval to extend the AHRQ Research Reporting System information collection with reduced annual burden and expanded scope to include grants, contracts, and challenge competitions.
Medicare's final rule strengthens oversight of accrediting organizations by addressing conflicts of interest, establishing consistent standards, and updating validation systems for deemed providers and suppliers across multiple care settings.
Center for Scientific Review will hold closed meetings to review grant applications and personnel matters; specific dates and locations available upon request to the designated agency contact.
FDA corrects withdrawal of approval for 11 abbreviated new drug applications; Masuu Global Solutions LLC's propranolol and lidocaine ANDAs remain approved as of March 23, 2026.
NIH submits its Extramural Harassment Web Form for OMB review under the Paperwork Reduction Act, with a 30-day public comment period.
HHS Office of the Secretary seeks public comments on an Information Collection Request through OMB review; the 30-day comment period is open now.
The National Cancer Institute offers licensing of the A1847 human ovarian carcinoma cell line, a BRCA1-deficient model for researchers studying cell cycle regulation, tumor suppression, and DNA damage repair drugs.
Proposed rule codifies Medicare Drug Price Negotiation Program under the Inflation Reduction Act of 2022 and establishes new policies for drug benefit programs and fixed combination drugs.
HRSA's Health Resources and Services Administration Uniform Data System information collection request is under OMB review with a 30-day public comment period; comments close before OMB approval decision.
HHS Office of Disease Prevention and Health Promotion solicits public comments on proposed Healthy People 2030 objectives and screen time measures to inform national health goals.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
